跳至主要内容
临床试验/NCT00351793
NCT00351793已完成不适用

A Clinical Trial Follow-up Study of the Genesis II Posterior Stabilized Total Knee Replacement

Ross Leighton1 个研究点 分布在 1 个国家目标入组 186 人开始时间: 2003年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
186
试验地点
1
主要终点
Effectiveness and Safety

研究概览

简要总结

The purpose of this study is to look at the outcomes of the GENESIS II Posterior Stabilized Total Knee Replacement.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •A combined deformity of <30 degrees = group 1
  • •A combined deformity of >30 degrees = group 2
  • •Patient is willing to consent to participate in the study
  • •Patient is available for follow-up through at least 2 years but preferably 5 years
  • •Patient has met acceptable preoperative medical clearance and is free of or treated for medical conditions that would pose excessive operative risk
  • •Patients who are fluent in English and are able to understand their role in a clinical trial

排除标准

  • •Active, local infection or systemic infection
  • •Fibromyalgia patients
  • •Patients whom, as judged by the surgeon, are not capable of understanding the informed consent or the requirements of the protocol and or are reasonably unlikely to be compliant with the prescribed routine and the follow-up evaluation schedule

结局指标

主要结局

Effectiveness and Safety

时间窗: 5 years

Will evaluate effectiveness and safety during a 5 year period via analysis of the Knee Society Score, revision status, and radiographic evaluation

次要结局

  • Western Ontario and MacMaster Universities Osteoarthritis Index (WOMAC)(Pre-op, 6 months, 1 year, 2 years, 5 years)
  • Knee Society Clinical Rating(Pre-op, 6 months, 1 year, 2 years, 5 years)

研究者

发起方
Ross Leighton
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ross Leighton

Orthopedic Surgeon

Nova Scotia Health Authority

研究点 (1)

Loading locations...

相似试验